HRMY

$37.02-2.35%

Harmony Biosciences Holdings, Inc.

Market Cap

$2.2B

Live price × SEC shares (Jul 31, 2026)

Sector

Health Care

Industry

Pharmaceuticals

Beta (raw)

0.99

60mo monthly vs SPY

P/E (TTM)

12.0

TTM to Jun 2026 · diluted EPS

P/S (TTM)

2.2

TTM to Jun 2026 · revenue

P/B

2.2

Mkt cap / shareholders' equity

EV/EBITDA (TTM)

—

EV / TTM EBITDA

Loading…

Financial Statements

USD thousands	Q3 FY2025 Sep 30, 2025	Q4 FY2025 Dec 31, 2025	Q1 FY2026 Mar 31, 2026	Q2 FY2026 Jun 30, 2026	TTM Jun 30, 2026
Revenue	239,455	243,776	215,387	261,280	959,898
Cost of revenue	59,650	68,545	44,512	63,198	235,905
Gross profit	179,805	175,231	170,875	198,082	723,993
Research & development	54,962	49,933	69,383	46,596	220,874
Total operating expenses	114,318	136,674	133,584	108,766	493,342
Operating income	65,487	38,557	37,291	89,316	230,651
Interest expense	3,621	3,546	3,234	3,070	13,471
Pretax income	67,490	40,760	39,687	93,265	241,202
Income tax	16,625	18,274	7,199	17,834	59,932
Net income	50,865	22,486	32,488	75,431	181,270
EPS (basic) ($)	0.88		0.56	1.30	3.13
EPS (diluted) ($)	0.87		0.55	1.28	3.09
Weighted avg. shares (basic)	57,551		57,819	57,934
Weighted avg. shares (diluted)	58,718		58,776	58,755

Source: SEC XBRL filings (10-K, 10-Q). Per-share data in dollars; shares in thousands. Latest: 10-Q filed Aug 4, 2026, period ended Jun 30, 2026. flagged for review— withheld, failed a consistency check restated or split-adjustedhover a value for its source

Showing the last 5 quarters. 24 more quarters, back to Sep 2019, with Tormere Pro.

Corporate Events (8-K)

1 filing in 12 months · 0 with priority itemsFull history →

Filed	Items	Filing
Oct 30, 2026 accepted 4:15 PM ET	8-K/A 5.02Officer / director change	Document SEC ↗

Signals

purchases / sales, 90d

Short Volume

81%

W/W +2.1pp

Market & Alt Data

News

Factor Profile

Pro

Pro feature

Fama-French factor analysis is available on the Pro plan.

Upgrade to Pro

Velocity Score

23.98x

Avg Daily Selling (90d)

805 sh/day

Baseline Daily Selling

0.0 sh/day

Unique Sellers (90d)

Sort by

Type

Trade Date	Filed	Owner	Role	Type	Shares	Price	Value	Owned After
2026-09-18	2026-09-18	Budur Kumar	CHIEF MEDICAL OFFICER	Sale	35.9K	$43.05	$1.54M	13.1K	View
2026-09-17	2026-09-18	Budur Kumar	CHIEF MEDICAL OFFICER	Sale	800	$43.00	$34K	13.1K	View
2026-09-16	2026-09-18	Budur Kumar	CHIEF MEDICAL OFFICER	Sale	1,800	$43.01	$77K	13.1K	View
2026-09-08	2026-09-09	Budur Kumar	CHIEF MEDICAL OFFICER	Sale	28.5K	$42.96	$1.22M	13.1K	View
2026-09-04	2026-09-09	Budur Kumar	CHIEF MEDICAL OFFICER	Sale	5,500	$41.98	$231K	18.6K	View

Recent News

Earnings To Watch: Harmony Biosciences Holdings Inc (HRMY) Q3 20

GuruFocus · 2026-11-03

Earnings To Watch: Harmony Biosciences Holdings Inc (HRMY) Q3 2026 -- GF Value Sees 45% Upside

Yahoo Finance · 2026-11-03

HRMY 261120 27.50P (HRMY261120P27500) Stock Options Chain | Quotes & News

Moomoo · 2026-11-03

Harmony Biosciences Holdings, I (HRMY) Stock Forecasts

Yahoo Finance · 2026-11-02

PTC Therapeutics (PTCT) Q3 Earnings and Revenues Surpass Estimates

Yahoo · 2026-10-29

Earnings Preview: BioAge Labs, Inc. (BIOA) Q3 Earnings Expected to Decline

Yahoo · 2026-10-29

GSK Q3 Earnings Top Mark, Stock Down on Soft Vaccines Sales

Yahoo · 2026-10-28

Harmony Biosciences Holdings, Inc. (HRMY) Reports Next Week: Wall Street Expects Earnings Growth

Yahoo · 2026-10-28

Harmony Biosciences Grapples With A Leadership Transition That Spooked Investors

Yahoo · 2026-10-28

BHC Q3 Earnings Preview: Here's What You Should Know

Yahoo · 2026-10-26

TNGX Stock Falls 16% Despite Positive Pancreatic Cancer Study Data

Yahoo · 2026-10-26

RDY Q2 Earnings & Revenues Miss Estimates as Lenalidomide Sales Fall

Yahoo · 2026-10-26

4 Small-Cap Stocks With Paths to Recovery After the Fed's September Rate Hike

Yahoo · 2026-10-26

HRMY or ARGX: Which Is the Better Value Stock Right Now?

Yahoo · 2026-10-22

Are Investors Undervaluing Harmony Biosciences (HRMY) Right Now?

Yahoo · 2026-10-22

Informational purposes only, not investment advice.

Date	Insider	Type	Shares	Value
2026-09-18	Budur Kumar	S	35,852	$2M
2026-09-17	Budur Kumar	S	800	$34,400
2026-09-16	Budur Kumar	S	1,800	$77,426.28
2026-09-08	Budur Kumar	S	22,954	$989,349.54
2026-09-08	Budur Kumar	S	4,500	$190,113.75

HRMY

Financial Statements

Corporate Events (8-K)

Signals

Factor Profile

Recent News

Harmony Biosciences Holdings, Inc. (HRMY)

Reporting Insiders

Factor Profile

Corporate Events (8-K)